Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes
US7208498B2 · kind B2 · utility
7Cited by
7References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 11, 2003 |
| Grant date | Apr 24, 2007 |
| Priority date | — |
| Expiry date | Mar 7, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to compounds which are inhibitors of the dipeptidyl peptidase-IV enzyme (“DP-IV inhibitors”) and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.